Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ISN-001 by Anterogen for Crohn's Disease (Regional Enteritis): Likelihood of Approval
ISN-001 is under clinical development by Anterogen and currently in Phase I for Crohn's Disease (Regional Enteritis). According to GlobalData,...